Search Results for "Smecta "

12:24 EDT 8th October 2015 | BioPortfolio

Matching Channels


Matching News

Ipsen reports strong sales growth in Q1 2015 and raises guidance for the year

Group sales up 11.7%1 Specialty care sales up 14.6%1 - Somatuline® up 25.0%1, driven by the launch in neuroendocrine tumors in the ...

Ipsen: 2015 Half-Year Results

Group sales up 7.9%1 driven by solid 12.0%1 growth of Specialty care, notably due to Somatuline® Core Operating Income up 3.5%, in view of the investmen...

Matching PubMed Articles


Search Whole site using Google


Advertisement Advertisement